For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Applied Therapeutics Inc (NASDAQ: APLT) closed at $0.41 in the last session, down -6.44% from day before closing price of $0.43. In other words, the price has decreased by -$6.44 from its previous closing price. On the day, 1.97 million shares were traded.
Ratios:
We take a closer look at APLT’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 3.06 and its Current Ratio is at 3.06. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On December 02, 2024, UBS Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $13 to $2.
RBC Capital Mkts Downgraded its Outperform to Sector Perform on November 29, 2024, whereas the target price for the stock was revised from $12 to $4.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 04 ’25 when Perfetti Riccardo sold 10,366 shares for $0.44 per share. The transaction valued at 4,561 led to the insider holds 890,409 shares of the business.
Funtleyder Leslie D. sold 14,502 shares of APLT for $6,381 on Mar 04 ’25. The insider now owns 390,459 shares after completing the transaction at $0.44 per share. On Mar 04 ’25, another insider, Chinoporos Constantine, who serves as the insider of the company, sold 447 shares for $0.44 each. As a result, the insider received 197 and left with 271,436 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 125.23 while its Price-to-Book (P/B) ratio in mrq is 0.98.
Stock Price History:
Over the past 52 weeks, APLT has reached a high of $10.62, while it has fallen to a 52-week low of $0.29. The 50-Day Moving Average of the stock is -10.01%, while the 200-Day Moving Average is calculated to be -89.25%.
Shares Statistics:
A total of 137.23M shares are outstanding, with a floating share count of 111.03M. Insiders hold about 21.57% of the company’s shares, while institutions hold 69.47% stake in the company.
Earnings Estimates
Applied Therapeutics Inc (APLT) is currently under the scrutiny of 4.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.18, with high estimates of -$0.13 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$0.46 and -$0.9 for the fiscal current year, implying an average EPS of -$0.66. EPS for the following year is -$0.3, with 2.0 analysts recommending between -$0.25 and -$0.34.
Revenue Estimates
According to 1 analysts, the current quarter’s revenue is expected to be $10M. It ranges from a high estimate of $10M to a low estimate of $10M. As of the current estimate, Applied Therapeutics Inc’s year-ago sales were $190k
A total of 4 analysts have provided revenue estimates for APLT’s current fiscal year. The highest revenue estimate was $10M, while the lowest revenue estimate was $5M, resulting in an average revenue estimate of $7.61M. In the same quarter a year ago, actual revenue was $455kBased on 3 analysts’ estimates, the company’s revenue will be $37.59M in the next fiscal year. The high estimate is $54.3M and the low estimate is $17.81M.
